Elon Musk's brain-implant company Neuralink says the US FDA had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval reut.rs/3MCI4IX (https://reut.rs/3MCI4IX)

https://nitter.moomoo.me/Reuters/status/1661998102130352128#m